Yunai Du

937 total citations · 1 hit paper
11 papers, 778 citations indexed

About

Yunai Du is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Yunai Du has authored 11 papers receiving a total of 778 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Biomaterials, 5 papers in Biomedical Engineering and 4 papers in Molecular Biology. Recurrent topics in Yunai Du's work include Nanoparticle-Based Drug Delivery (5 papers), Nanoplatforms for cancer theranostics (5 papers) and RNA Interference and Gene Delivery (3 papers). Yunai Du is often cited by papers focused on Nanoparticle-Based Drug Delivery (5 papers), Nanoplatforms for cancer theranostics (5 papers) and RNA Interference and Gene Delivery (3 papers). Yunai Du collaborates with scholars based in China and United States. Yunai Du's co-authors include Chunmeng Sun, Jiasheng Tu, Liping Huang, Yuan Ding, Fanling Meng, Liang Luo, Xiuxia Wang, Xiangliang Yang, Yiyi Zhang and Yanan Li and has published in prestigious journals such as Nature Communications, Advanced Functional Materials and Journal of Controlled Release.

In The Last Decade

Yunai Du

11 papers receiving 773 citations

Hit Papers

Mild photothermal therapy potentiates anti-PD-L1 treatmen... 2019 2026 2021 2023 2019 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yunai Du China 9 549 232 217 203 134 11 778
Fengyun Shen China 14 491 0.9× 328 1.4× 239 1.1× 210 1.0× 128 1.0× 26 829
Yuanji Feng China 13 427 0.8× 297 1.3× 275 1.3× 159 0.8× 130 1.0× 22 756
DaeYong Lee South Korea 19 481 0.9× 443 1.9× 255 1.2× 245 1.2× 182 1.4× 33 1.0k
Asmita Banstola South Korea 15 489 0.9× 203 0.9× 185 0.9× 316 1.6× 90 0.7× 21 744
Mengsi Zhan China 16 484 0.9× 342 1.5× 203 0.9× 247 1.2× 130 1.0× 37 869
Mengyun Liang China 16 542 1.0× 409 1.8× 189 0.9× 252 1.2× 140 1.0× 27 858
Mixiao Tan China 13 442 0.8× 260 1.1× 124 0.6× 195 1.0× 141 1.1× 21 735
Yue Yan China 16 535 1.0× 384 1.7× 184 0.8× 258 1.3× 172 1.3× 39 876
Zar Chi Soe South Korea 16 559 1.0× 295 1.3× 205 0.9× 426 2.1× 176 1.3× 21 957

Countries citing papers authored by Yunai Du

Since Specialization
Citations

This map shows the geographic impact of Yunai Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunai Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunai Du more than expected).

Fields of papers citing papers by Yunai Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunai Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunai Du. The network helps show where Yunai Du may publish in the future.

Co-authorship network of co-authors of Yunai Du

This figure shows the co-authorship network connecting the top 25 collaborators of Yunai Du. A scholar is included among the top collaborators of Yunai Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunai Du. Yunai Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Chen, Dali, Yunai Du, Huihong Li, et al.. (2025). Phase-separating Pt(IV)-graft-glycopeptides sequentially sensing pH and redox for deep tumor penetration and targeting chemotherapy. Journal of Controlled Release. 379. 743–756. 5 indexed citations
2.
Chen, Qian, Yanan Li, Liping Huang, et al.. (2023). Nano-vaccines combining customized in situ anti-PD-L1 depot for enhanced tumor immunotherapy. Nanomedicine Nanotechnology Biology and Medicine. 53. 102693–102693. 6 indexed citations
3.
Wang, Sheng, Jingwen Zhang, Wei Li, et al.. (2022). Hyaluronic acid-guided assembly of ceria nanozymes as plaque-targeting ROS scavengers for anti-atherosclerotic therapy. Carbohydrate Polymers. 296. 119940–119940. 47 indexed citations
4.
Du, Yunai, Yanan Li, Xuezhao Li, et al.. (2020). Sequential Enzyme Activation of a “Pro‐Staramine”‐Based Nanomedicine to Target Tumor Mitochondria. Advanced Functional Materials. 30(9). 23 indexed citations
5.
Du, Yunai, Sheng Wang, Tianhao Zhang, et al.. (2020). Enhanced cytotoxicity of a redox-sensitive hyaluronic acid-based nanomedicine toward different oncocytes via various internalization mechanisms. Drug Delivery. 27(1). 128–136. 15 indexed citations
6.
Huang, Liping, Yanan Li, Yunai Du, et al.. (2019). Mild photothermal therapy potentiates anti-PD-L1 treatment for immunologically cold tumors via an all-in-one and all-in-control strategy. Nature Communications. 10(1). 4871–4871. 509 indexed citations breakdown →
7.
Chaurasiya, Birendra, et al.. (2018). Size-based anti-tumoral effect of paclitaxel loaded albumin microparticle dry powders for inhalation to treat metastatic lung cancer in a mouse model. International Journal of Pharmaceutics. 542(1-2). 90–99. 16 indexed citations
8.
Du, Yunai, Liping Huang, Birendra Chaurasiya, et al.. (2018). Redox-responsive micelles from disulfide bond-bridged hyaluronic acid-tocopherol succinate for the treatment of melanoma. Nanomedicine Nanotechnology Biology and Medicine. 14(3). 713–723. 52 indexed citations
9.
Huang, Liping, Birendra Chaurasiya, Dawei Wu, et al.. (2018). Versatile redox-sensitive pullulan nanoparticles for enhanced liver targeting and efficient cancer therapy. Nanomedicine Nanotechnology Biology and Medicine. 14(3). 1005–1017. 55 indexed citations
10.
Huang, Liping, Yutong Wang, Xiang Ling, et al.. (2016). Efficient delivery of paclitaxel into ASGPR over-expressed cancer cells using reversibly stabilized multifunctional pullulan nanoparticles. Carbohydrate Polymers. 159. 178–187. 30 indexed citations
11.
Li, Maozhong, Yunai Du, Chunmeng Sun, et al.. (2015). Risk assessment of supply chain for pharmaceutical excipients with AHP-fuzzy comprehensive evaluation. Drug Development and Industrial Pharmacy. 42(4). 676–684. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026